Variant report
Variant | esv3397939 |
---|---|
Chromosome Location | chr1:228757647-228760264 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:129)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL3 | chr1:228757842-228758009 | GM12878 | blood: | n/a | n/a |
2 | BCL3 | chr1:228757836-228758031 | GM12878 | blood: | n/a | n/a |
3 | CBX3 | chr1:228759936-228766629 | K562 | blood: | n/a | n/a |
4 | CBX3 | chr1:228756716-228760610 | K562 | blood: | n/a | n/a |
5 | CBX3 | chr1:228756779-228759666 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr1:228757789-228758242 | GM12878 | blood: | n/a | n/a |
7 | CEBPB | chr1:228760026-228760632 | GM12878 | blood: | n/a | n/a |
8 | CEBPB | chr1:228759206-228759599 | K562 | blood: | n/a | n/a |
9 | CEBPD | chr1:228759235-228759657 | K562 | blood: | n/a | n/a |
10 | CEBPD | chr1:228757823-228758348 | K562 | blood: | n/a | n/a |
11 | CTCF | chr1:228759359-228760804 | K562 | blood: | n/a | chr1:228760087-228760096 chr1:228760084-228760097 chr1:228760677-228760690 |
12 | CTCF | chr1:228757994-228758420 | K562 | blood: | n/a | n/a |
13 | CTCF | chr1:228757848-228758573 | K562 | blood: | n/a | chr1:228758435-228758448 chr1:228757867-228757876 chr1:228757864-228757877 |
14 | CTCF | chr1:228758159-228758196 | LNCaP | prostate: | n/a | n/a |
15 | CTCF | chr1:228758836-228759127 | K562 | blood: | n/a | n/a |
16 | CTCF | chr1:228758026-228758427 | K562 | blood: | n/a | n/a |
17 | CTCF | chr1:228760241-228760669 | K562 | blood: | n/a | n/a |
18 | CTCF | chr1:228758155-228758222 | GM10248 | blood: | n/a | n/a |
19 | CTCF | chr1:228758160-228758231 | Spleen_OC | spleen: | n/a | n/a |
20 | FOSL2 | chr1:228758822-228759034 | HepG2 | liver: | n/a | chr1:228758886-228758895 |
21 | FOSL2 | chr1:228758055-228758374 | HepG2 | liver: | n/a | n/a |
22 | FOXA2 | chr1:228759210-228759822 | A549 | lung: | n/a | n/a |
23 | FOXA2 | chr1:228743895-228782766 | A549 | lung: | n/a | n/a |
24 | FOXM1 | chr1:228759232-228759666 | GM12878 | blood: | n/a | n/a |
25 | FOXP2 | chr1:228759414-228759659 | PFSK-1 | brain: | n/a | n/a |
26 | FOXP2 | chr1:228759330-228759681 | SK-N-MC | brain: | n/a | n/a |
27 | FOXP2 | chr1:228757454-228757695 | PFSK-1 | brain: | n/a | n/a |
28 | FOXP2 | chr1:228757816-228758427 | PFSK-1 | brain: | n/a | n/a |
29 | FOXP2 | chr1:228759944-228760263 | PFSK-1 | brain: | n/a | n/a |
30 | GABPA | chr1:228758131-228758317 | Hela-S3 | cervix: | n/a | n/a |
31 | GABPA | chr1:228758853-228758963 | Hela-S3 | cervix: | n/a | n/a |
32 | GATA2 | chr1:228758053-228758307 | K562 | blood: | n/a | n/a |
33 | HEY1 | chr1:228758812-228759008 | HepG2 | liver: | n/a | chr1:228758865-228758880 chr1:228758971-228758986 chr1:228758974-228758989 |
34 | HEY1 | chr1:228758051-228758399 | HepG2 | liver: | n/a | n/a |
35 | HEY1 | chr1:228758829-228759014 | K562 | blood: | n/a | chr1:228758865-228758880 chr1:228758971-228758986 chr1:228758974-228758989 |
36 | HEY1 | chr1:228758056-228758234 | K562 | blood: | n/a | n/a |
37 | HEY1 | chr1:228758068-228758315 | K562 | blood: | n/a | n/a |
38 | JUND | chr1:228759199-228759669 | A549 | lung: | n/a | n/a |
39 | JUND | chr1:228758850-228758966 | HepG2 | liver: | n/a | chr1:228758886-228758895 |
40 | JUND | chr1:228744099-228759006 | A549 | lung: | n/a | chr1:228748791-228748805 chr1:228747728-228747737 chr1:228753273-228753287 chr1:228744309-228744323 chr1:228746550-228746564 chr1:228745487-228745496 chr1:228755514-228755528 chr1:228751032-228751046 chr1:228758886-228758895 chr1:228749969-228749978 chr1:228752210-228752219 chr1:228754451-228754460 chr1:228757729-228757743 |
41 | JUND | chr1:228759031-228765239 | A549 | lung: | n/a | chr1:228759949-228759963 chr1:228764430-228764444 chr1:228762191-228762205 chr1:228761128-228761137 chr1:228763367-228763376 |
42 | MYBL2 | chr1:228759036-228759828 | HepG2 | liver: | n/a | n/a |
43 | MYBL2 | chr1:228760003-228760669 | HepG2 | liver: | n/a | n/a |
44 | MYBL2 | chr1:228759927-228760773 | HepG2 | liver: | n/a | n/a |
45 | MYBL2 | chr1:228756565-228759813 | HepG2 | liver: | n/a | n/a |
46 | NFIC | chr1:228757787-228758156 | GM12878 | blood: | n/a | n/a |
47 | NR2F2 | chr1:228757758-228758493 | K562 | blood: | n/a | n/a |
48 | NR2F2 | chr1:228759271-228759659 | K562 | blood: | n/a | n/a |
49 | NR2F2 | chr1:228759065-228759582 | K562 | blood: | n/a | n/a |
50 | PAX5 | chr1:228758239-228758373 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5S6 | TF binding region |
RNA5S7 | TF binding region |
RNA5S5 | TF binding region |
RNA5S4 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552151310 | chr1:228757925-228757926 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs559449286 | chr1:228757926-228757927 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs200234224 | chr1:228757935-228757936 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs61825676 | chr1:228757936-228757937 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs548519035 | chr1:228757938-228757939 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs79154558 | chr1:228757942-228757943 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs568592811 | chr1:228757947-228757948 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs74748147 | chr1:228757948-228757949 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs551296850 | chr1:228757984-228757985 | Bivalent/Poised TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs61825677 | chr1:228758016-228758017 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs61825678 | chr1:228758027-228758028 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs190428826 | chr1:228758044-228758045 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs11484728 | chr1:228758055-228758056 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs11484729 | chr1:228758060-228758061 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs11484730 | chr1:228758124-228758125 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs11487481 | chr1:228758138-228758139 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs11484731 | chr1:228758140-228758141 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs374779647 | chr1:228758164-228758165 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs1925725 | chr1:228758170-228758171 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs11484732 | chr1:228758186-228758187 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs558568148 | chr1:228758188-228758189 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs565793485 | chr1:228758198-228758199 | Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs534690233 | chr1:228758338-228758339 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs112693194 | chr1:228758473-228758474 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228756800-228757800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr1:228757000-228771000 | Weak transcription | Right Atrium | heart |
3 | chr1:228757800-228758000 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr1:228757800-228758200 | Bivalent/Poised TSS | H1 Cell Line | embryonic stem cell |
5 | chr1:228757800-228758200 | Active TSS | Adipose Nuclei | Adipose |
6 | chr1:228757800-228758200 | Active TSS | Fetal Stomach | stomach |
7 | chr1:228757800-228758200 | Active TSS | Dnd41 | blood |
8 | chr1:228757800-228758200 | Active TSS | HSMM | muscle |
9 | chr1:228758000-228758200 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |